Immediate Impact

1 from Science/Nature 34 standout
Sub-graph 1 of 17

Citing Papers

Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Poly(l‐Histidine)‐Mediated On‐Demand Therapeutic Delivery of Roughened Ceria Nanocages for Treatment of Chemical Eye Injury
2023 Standout
2 intermediate papers

Works of J. S. Kennerdell being referenced

Eye Muscle Antibodies in Patients with Ocular Myasthenia Gravis: Possible Mechanism for Eye Muscle Inflammation in Acetylcholine-Receptor Antibody-Negative Patients
1998
Levels of manganese superoxide dismutase activity are increased in tears from patients with thyroid-associated ophthalmopathy
1996

Author Peers

Author Last Decade Papers Cites
J. S. Kennerdell 345 218 210 225 28 652
Hui‐Chuan Kau 353 149 107 333 40 816
Brent Hayek 479 287 213 230 26 753
C Lane 324 234 85 218 27 690
Onur Konuk 361 189 168 310 38 632
Mohammad H. Naheedy 118 122 215 103 37 724
Ruth van der Gaag 344 229 85 212 26 768
James W. Gigantelli 461 274 177 208 17 650
James A. Rush 309 77 470 209 22 744
Nathan S. Schlezinger 199 123 380 72 22 582
Rachel Kalmann 514 362 145 214 26 740

All Works

Loading papers...

Rankless by CCL
2026